CXCL12 is essential for migration of activated Langerhans cells from epidermis to dermis

European Journal of Immunology

Volumn 38, Issue 11, 2008, Pages 3050-3059

  Ouwehand, Krista ^a   Santegoets, Saskia J A M ^a   Bruynzeel, Derk P ^a   Scheper, Rik J ^a   de Gruijl, Tanja D ^a   Gibbs, Susan ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Allergy; Chemotaxis; Cytokines; DC; Skin

Indexed keywords

ALLERGEN; CHEMOKINE RECEPTOR CXCR4; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; SECONDARY LYMPHOID TISSUE CHEMOKINE; STROMAL CELL DERIVED FACTOR 1; CXCL12 PROTEIN, HUMAN; CXCR4 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DERMIS; DOWNSTREAM PROCESSING; EPIDERMIS; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LANGERHANS CELL; LYMPH NODE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; UPREGULATION; ADULT; CELL CULTURE; CELL MOTION; IMMUNOLOGY; PHYSIOLOGY; SKIN;

ADULT; ALLERGENS; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CXCL12; EPIDERMIS; HUMANS; LANGERHANS CELLS; RECEPTORS, CXCR4; SKIN;

EID: 58149339761     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200838384     Document Type: Article

References (49)

1. Jakob, T., Ring, J. and Udey, M. C., Multistep navigation of Langerhans/dendritic cells in and out of the skin. J. Allergy Clin. Immunol. 2001. 108: 688-696.
2. Cumberbatch, M., Dearman, R. J., Griffiths, C. E. and Kimber, I., Langerhans cell migration. Clin. Exp. Dermatol. 2000. 25: 413-418.
3. Aiba, S., Terunuma, A., Manome, H. and Tagami, H., Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of co-stimulatory molecules. Eur. J. Immunol. 1997. 27: 3031-3038.
4. Kimber, I., Cumberbatch, M., Dearman, R. J., Bhushan, M. and Griffiths, C. E., Cytokines and chemokines in the initiation and regulation of epidermal Langerhans cell mobilization. Br. J. Dermatol. 2000. 142: 401-412.
5. Sozzani, S., Allavena, P., Vecchi, A. and Mantovani, A., Chemokines and dendritic cell traffic. J. Clin. Immunol. 2000. 20: 151-160.
6. Ohl, L., Mohaupt, M., Czeloth, N., Hintzen, G., Kiafard, Z., Zwirner, J., Blankenstein, T. et al., CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 2004. 21: 279-288.
7. Gunn, M. D., Kyuwa, S., Tam, C., Kakiuchi, T., Matsuzawa, A., Williams, L. T. and Nakano, H., Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J. Exp. Med. 1999. 189: 451-460.
8. Forster, R., Schubel, A., Breitfeld, D., Kremmer, E., Renner-Muller, I., Wolf, E. and Lipp, M., CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 1999. 99: 23-33.
9. Kellermann, S. A., Hudak, S., Oldham, E. R., Liu, Y. J. and McEvoy, L. M., The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3 beta are potent chemoattractants for in vitro- and in vivo-derived dendritic cells. J. Immunol. 1999. 162: 3859-3864.
10. Saeki, H., Moore, A. M., Brown, M. J. and Hwang, S. T., Cutting edge: Secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J. Immunol. 1999. 162: 2472-2475.
11. Yanagihara, S., Komura, E., Nagafune, J., Watarai, H. and Yamaguchi, Y., EBI1/CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation. J. Immunol. 1998. 161: 3096-3102.
12. Yoshida, R., Imai, T., Hieshima, K., Kusuda, J., Baba, M., Kitaura, M., Nishimura, M. et al., Molecular cloning of a novel human CC chemokine EBI1-ligand chemokine that is a specific functional ligand for EBI1, CCR7. J. Biol. Chem. 1997. 272: 13803-13809.
13. Hedrick, J. A. and Zlotnik, A., Identification and characterization of a novel beta chemokine containing six conserved cysteines. J. Immunol. 1997. 159: 1589-1593.
14. Cumberbatch, M., Scott, R. C., Basketter, D. A., Scholes, E. W., Hilton, J., Dearman, R. J. and Kimber, I., Influence of sodium lauryl sulphate on 2,4-dinitrochlorobenzene-induced lymph node activation. Toxicology 1993. 77: 181-191.
15. Carramolino, L., Kremer, L., Goya, I., Varona, R., Buesa, J. M., Gutierrez, J., Zaballos, A. et al., Down-regulation of the beta-chemokine receptor CCR6 in dendritic cells mediated by TNF-alpha and IL-4. J. Leukoc. Biol. 1999. 66: 837-844.
16. Greaves, D. R., Wang, W., Dairaghi, D. J., Dieu, M. C., Saint-Vis, B., Franz-Bacon, K., Rossi, D. et al., CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3alpha and is highly expressed in human dendritic cells. J. Exp. Med. 1997. 186: 837-844.
17. Dieu-Nosjean, M. C., Massacrier, C., Homey, B., Vanbervliet, B., Pin, J. J., Vicari, A., Lebecque, S. et al., Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. J. Exp. Med. 2000. 192: 705-718.
18. Tohyama, M., Shirakara, Y., Yamasaki, K., Sayama, K. and Hashimoto, K., Differentiated keratinocytes are responsible for TNF-alpha regulated production of macrophage inflammatory protein 3alpha/CCL20, a potent chemokine for Langerhans cells. J. Dermatol. Sci. 2001. 27: 130-139.
19. Spiekstra, S. W., Toebak, M. J., Sampat-Sardjoepersad, S., van Beek, P. J., Boorsma, D. M., Stoof, T. J., von Blomberg, B. M. et al., Induction of cytokine (interleukin-1alpha and tumor necrosis factor-alpha) and chemokine (CCL20, CCL27, and CXCL8) alarm signals after allergen and irritant exposure. Exp. Dermatol. 2005. 14: 109-116.
20. Kobayashi, Y., Staquet, M. J., Dezutter-Dambuyant, C. and Schmitt, D., Development of motility of Langerhans cell through extracellular matrix by in vitro hapten contact. Eur. J. Immunol. 1994. 24: 2254-2257.
21. Oberlin, E., Amara, A., Bachelerie, F., Bessia, C., Virelizier, J. L., Arenzana- Seisdedos, F., Schwartz, O. et al., The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 1996. 382: 833-835.
22. Bleul, C. C., Farzan, M., Choe, H., Parolin, C., Clark-Lewis, I., Sodroski, J. and Springer, T. A., The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 1996. 382: 829-833.
23. Avniel, S., Arik, Z., Maly, A., Sagie, A., Basst, H. B., Yahana, M. D., Weiss, I. D. et al., Involvement of the CXCL12/CXCR4 pathway in the recovery of skin following burns. J. Invest Dermatol. 2006. 126: 468-476.
24. Ponomaryov, T., Peled, A., Petit, I., Taichman, R. S., Habler, L., Sandbank, J., Arenzana-Seisdedos, F. et al., Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function. J. Clin. Invest 2000. 106: 1331-1339.
25. Askari, A. T., Unzek, S., Popovic, Z. B., Goldman, C. K., Forudi, F., Kiedrowski, M., Rovner, A. et al., Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003. 362: 697-703.
26. Pablos, J. L., Amara, A., Bouloc, A., Santiago, B., Caruz, A., Galindo, M., Delaunay, T. et al., Stromal-cell derived factor is expressed by dendritic cells and endothelium in human skin. Am. J. Pathol. 1999. 155: 1577-1586.
27. Gombert, M., Dieu-Nosjean, M. C., Winterberg, F., Bunemann, E., Kubitza, R. C., Da Cunha, L., Haahtela, A. et al., CCL1-CCR8 interactions: An axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation. J. Immunol. 2005. 174: 5082-5091.
28. Rustemeyer, T., Preuss, M., von Blomberg, B. M., Das, P. K. and Scheper, R. J., Comparison of two in vitro dendritic cell maturation models for screening contact sensitizers using a panel of methacrylates. Exp. Dermatol. 2003. 12: 682-691.
29. Zoeteweij, J. P., Golding, H., Mostowski, H. and Blauvelt, A., Cytokines regulate expression and function of the HIV coreceptor CXCR4 on human mature dendritic cells. J. Immunol. 1998. 161: 3219-3223.
30. Tchou, I., Misery, L., Sabido, O., Dezutter-Dambuyant, C., Bourlet, T., Moja, P., Hamzeh, H. et al., Functional HIV CXCR4 coreceptor on human epithelial Langerhans cells and infection by HIV strain X4. J. Leukoc. Biol. 2001. 70: 313-321.
31. Aiuti, A.,Webb, I. J., Bleul, C., Springer, T. and Gutierrez-Ramos, J. C., The chemokine SDF-1 is a chemoattractant for human CD341 hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J. Exp. Med. 1997. 185: 111-120.
32. Humrich, J. Y., Humrich, J. H., Averbeck, M., Thumann, P., Termeer, C., Kampgen, E., Schuler, G. and Jenne, L., Mature monocyte-derived dendritic cells respond more strongly to CCL19 than to CXCL12: consequences for directional migration. Immunology 2006. 117: 238-247.
33. Ganju, R. K., Brubaker, S. A., Meyer, J., Dutt, P., Yang, Y., Qin, S., Newman, W. and Groopman, J. E., The alpha-chemokine, stromal cell-derived factor-1alpha, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways. J. Biol. Chem. 1998. 273: 23169-23175.
34. Masterson, A. J., Sombroek, C. C., De Gruijl, T. D., Graus, Y. M., van der Vliet, H. J., Lougheed, S. M., van den Eertwegh, A. J. et al., MUTZ-3, a human cell line model for the cytokine-induced differentiation of dendritic cells from CD34+ precursors. Blood 2002. 100: 701-703.
35. Santegoets, S. J., Masterson, A. J., van der Sluis, P. C., Lougheed, S. M., Fluitsma, D. M., van den Eertwegh, A. J., Pinedo, H. M. et al., A CD34(+) human cell line model of myeloid dendritic cell differentiation: Evidence for a CD14(+)CD11b(+) Langerhans cell precursor. J. Leukoc. Biol. 2006. 80: 1337-1344.
36. Larsson, K., Lindstedt, M. and Borrebaeck, C. A., Functional and transcriptional profiling of MUTZ-3, a myeloid cell line acting as a model for dendritic cells. Immunology 2006. 117: 156-166.
37. Schwarzenberger, K. and Udey, M. C., Contact allergens and epidermal proinflammatory cytokines modulate Langerhans cell E-cadherin expression in situ. J. Invest Dermatol. 1996. 106: 553-558.
38. Griffiths, C. E., Dearman, R. J., Cumberbatch, M. and Kimber, I., Cytokines and Langerhans cell mobilisation in mouse and man. Cytokine 2005. 32: 67-70.
39. Lisby, S., Muller, K. M., Jongeneel, C. V., Saurat, J. H. and Hauser, C., Nickel and skin irritants up-regulate tumor necrosis factor-alpha mRNA in keratinocytes by different but potentially synergistic mechanisms. Int. Immunol. 1995. 7: 343-352.
40. Smith, H. R., Basketter, D. A. and McFadden, J. P., Irritant dermatitis, irritancy and its role in allergic contact dermatitis. Clin. Exp. Dermatol. 2002. 27: 138-146.
41. Cumberbatch, M., Dearman, R. J., Antonopoulos, C., Groves, R. W. and Kimber, I., Interleukin (IL)-18 induces Langerhans cell migration by a tumour necrosis factor-alpha- and IL-1beta-dependent mechanism. Immunology 2001. 102: 323-330.
42. Cumberbatch, M., Dearman, R. J., Groves, R. W., Antonopoulos, C. and Kimber, I., Differential regulation of epidermal Langerhans cell migration by interleukins (IL)-1alpha and IL-1beta during irritant- and allergen-induced cutaneous immune responses. Toxicol. Appl. Pharmacol. 2002. 182: 126-135.
43. Enk, A. H., Angeloni, V. L., Udey, M. C. and Katz, S. I., An essential role for Langerhans cell-derived IL-1 beta in the initiation of primary immune responses in skin. J. Immunol. 1993. 150: 3698-3704.
44. Ogura, N., Tobe, M., Sakamaki, H., Nagura, H., Abiko, Y. and Kondoh, T., Tumor necrosis factor-alpha increases chemokine gene expression and production in synovial fibroblasts from human temporomandibular joint. J. Oral Pathol. Med. 2005. 34: 357-363.
45. Brouty-Boye, D., Pottin-Clemenceau, C., Doucet, C., Jasmin, C. and Azzarone, B., Chemokines and CD40 expression in human fibroblasts. Eur. J. Immunol. 2000. 30: 914-919.
46. Allan, R. S., Smith, C. M., Belz, G. T., van Lint, A. L., Wakim, L. M., Heath, W. R. and Carbone, F. R., Epidermal viral immunity induced by CD8alpha +dendritic cells but not by Langerhans cells. Science 2003. 301: 1925-1928.
47. Bennett, C. L., van Rijn, E., Jung, S., Inaba, K., Steinman, R. M., Kapsenberg, M. L. and Clausen, B. E., Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J. Cell Biol. 2005. 169: 569-576.
48. Kaplan, D. H., Jenison, M. C., Saeland, S., Shlomchik, W. D. and Shlomchik, M. J., Epidermal Langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity 2005. 23: 611-620.
49. Kabashima, K., Shiraishi, N., Sugita, K., Mori, T., Onoue, A., Kobayashi, M., Sakabe, J. I. et al., CXCL12-CXCR4 engagement is required for migration of cutaneous dendritic cells. Am. J. Pathol. 2007. 170: 1249-1257.